Form 4: Viatris CCO Sells Shares Under Pre-Arranged 10b5-1 Plan

Viatris's Chief Commercial Officer, Corinne Le Goff, sold 7,032 shares of common stock for approximately $10.25 per share under a pre-arranged trading plan.

Summary

• Corinne Le Goff, Chief Commercial Officer of Viatris Inc. (VTRS), disposed of 7,032 shares of the company's common stock.
• The transaction occurred on September 11, 2025, at a weighted average price of $10.2453 per share.
• The sale was executed pursuant to a Rule 10b5-1(c) trading plan, which was adopted by Ms. Le Goff on June 12, 2025.
• Following this transaction, Ms. Le Goff beneficially owns 35,299 shares of Viatris common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction under a pre-arranged 10b5-1 plan, which is generally considered neutral as it is for personal financial planning and not typically indicative of a change in company fundamentals or management's immediate outlook.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction under a pre-arranged trading plan, which is common practice for corporate executives for personal financial management and typically does not reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: A routine insider sale under a 10b5-1 plan typically has minimal direct impact on shareholders, as it is a pre-scheduled event for personal financial management rather than a signal of company-specific issues.

Key Dates

Recommendation

The reported transaction is a routine insider sale by a Chief Commercial Officer executed under a pre-arranged 10b5-1 trading plan. Such plans are established in advance to allow insiders to sell shares without being accused of trading on material non-public information. This type of transaction is generally for personal financial planning purposes and does not typically signal a change in the company's fundamental prospects or warrant an immediate alteration to an investment recommendation. Investors should continue to evaluate Viatris based on its broader financial performance, strategic initiatives, and market conditions.

Keywords

Viatris, VTRS, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Corinne Le Goff, Chief Commercial Officer